New test will revolutionise the treatment of childhood cancer

Jul 23, 2010

A test which will revolutionise the approach to tackling childhood cancer and improve the quality of life for hundreds of sufferers, has been given approval to be introduced across Europe.

Researchers at Newcastle University, funded by the UK’s largest brain tumour charity, The Samantha Dickson Tumour Trust, have developed the test for Medulloblastoma, the most common malignant childhood .

It will allow doctors to determine a much more detailed understanding of the severity of a tumour enabling more appropriate treatment options and a more accurate prognosis.

The test, which has just been approved for implementation across Europe at the International Society for Paediatric Neuro-Oncology Conference in Vienna, will pave the way for the development of similar tests across other tumour types.

Professor Steve Clifford, who led the research team at Newcastle University, said: “This test is incredibly significant in our understanding of this tumour type and it will lead to children being treated much more appropriately. 

"Before now, sufferers have been treated in a uniform way. Now we will be able to tell which of the children are at a lower risk and have a much higher chance of survival. Those at low risk can be given less , which could significantly diminish long term treatment side effects such as , attention deficit and learning difficulties."

Chairman of the Trust, Neil Dickson, who was at the Vienna Conference, says: “This is one of the biggest breakthroughs in the treatment relating to this tumour type.  Over the next few years we will have three different treatment regimes which will aim to reduce side effects for one group of patients and increase survivability for the other groups."

Explore further: Radiation-free method to track suspicious lymph nodes in case of cancer

Provided by Newcastle University

4 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Delays in UK child brain tumor diagnosis

Aug 07, 2009

Significant numbers of children in the UK are suffering from preventable levels of disability, particularly blindness, and premature death because of poor diagnosis of brain tumours.

Study finds biological clue in brain tumour development

Mar 18, 2009

(PhysOrg.com) -- Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for a children's brain tumour that currently kills more than 60 per cent ...

Recommended for you

Is the HPV vaccine necessary?

4 hours ago

As the school year starts in full swing many parents wonder if their child should receive the HPV vaccine, which is recommended for girls ages 11-26 and boys 11-21. There are a lot of questions and controversy around this ...

User comments : 0